Health ❯ Healthcare ❯ Cancer Treatment

Hormone Therapy

Androgen Deprivation Therapy Enzalutamide Apalutamide Selective Estrogen Receptor Degraders Therapeutic Targets Side Effects Androgen Receptor Pathway Inhibitors Estrogen Receptor-Positive Breast Cancer

Erleada Plus Hormone Therapy Cuts Recurrence and Death in High‑Risk Localized Prostate Cancer

Late‑stage trial results signal possible expansion of the Johnson & Johnson drug into earlier‑stage care and now move to regulatory review.

Slow-Cycling ER-Positive Cells Linked to Late Breast Cancer Relapse

Metformin Triggers Exercise-Linked Signal in Prostate Cancer Patients

Roche’s Giredestrant Plus Everolimus Extends PFS in Phase 3 evERA for ER-Positive, HER2-Negative Breast Cancer

Two Classes of FOXA1 Mutations Drive Prostate Cancer Initiation and Treatment Resistance